MedTrace Logo

Storytelling for Provider Empathy & Patient Trust in Obstetric Care

NCT07588308 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-05-14

No results posted yet for this study

Summary

Aim 3 is a provider-focused pilot randomized controlled trial evaluating a digital storytelling intervention to increase obstetric care providers' empathy and to examine associations with postpartum patient trust. Providers randomized to the intervention view a video of Black women's labor pain and care experiences and complete a brief reflection; control providers receive general culturally sensitive care materials. Outcomes include change in provider empathy (primary) and patient trust among Black postpartum patients under those providers' care (secondary). Risks are minimal and mitigated via consent, voluntary participation, the option to skip questions, and secure data practices.

Conditions

  • Pregnancy
  • Labor Pain

Interventions

BEHAVIORAL

Digital storytelling video + written reflection

Providers in the intervention arm watch a digital storytelling video and complete a brief written reflection to ensure engagement.

BEHAVIORAL

General culturally sensitive care materials

Providers in the control arm receive general written information about culturally sensitive care.

Sponsors & Collaborators

  • Rita & Alex Hillman Foundation

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Hideyo Tsumura · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-07-31
Completion
2026-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07588308 on ClinicalTrials.gov